09. 11(Thu)
09. 11(Thu) 13:00~14:30 Room 1
TBD
09. 11(Thu) 13:00~14:30 Room 2
Cutting-edge Nutritional Approach for Cardiometaboic Risk Strategies
09. 11(Thu) 13:00~14:30 Room 3
TBD
09. 11(Thu) 13:00~14:30 Room 4
Lipid Metabolism at the Crossroads of Inflammation, Toxicity, and Atherosclerosis
- From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events 13:00~13:20
- Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions 13:20~13:40
- Lipidomics based understanding of human disease 13:40~14:00
- Panel Discussion 14:00~14:30
09. 11(Thu) 14:40~16:10 Room 1
09. 11(Thu) 14:40~16:10 Room 2
TBD
09. 11(Thu) 14:40~16:10 Room 3
CVD Risk Prediction in Special Population
09. 11(Thu) 14:40~16:10 Room 4
Redefining Cardiovascular Care: PCSK9 Mechanisms and siRNA-Based Advances
- Deep dive into PCSK9: the master regulator of LDL metabolism and inflammation 14:40~15:00
- siRNA-based lipid therapies: a revolution in cholesterol management 15:00~15:20
- Expanding the horizons: siRNA applications beyond LDL cholesterol in cardiovascular disease 15:20~15:40
- Panel Discussion 15:40~16:10
09. 11(Thu) 16:20~17:50 Room 1
Recent Prognostic Evidence for the Triglyceride-Glucose (TyG) Index as a Novel Surrogate Marker of Insulin Resistance
09. 11(Thu) 16:20~17:50 Room 2
Familial Hypercholesterolemia (FH) in the Era of Precision Medicine
09. 11(Thu) 16:20~17:50 Room 3
How Low is Low Enough for LDL-C in Diabetes?
09. 11(Thu) 16:20~17:50 Room 4
Socioeconomic Status: The Missing Piece in Cardiovascular Risk Stratification
